We first used the expression profiling data to determine the human lung cancer subtype we were modeling in the SPC-IGFIR and SPC-IGFIR-Akt2−/− tumors and whether loss of Akt2 altered the lung tumor subtype. Here, AKT2 is linked to lung carcinoma.